Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DOVATO
- Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
- Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
- Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)
- Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
- A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants
- Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)
- Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF
- 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
- Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults
Clinical trials list
click for details